by
John R. Fischer, Senior Reporter | January 10, 2022
Prior to this, the company’s general manager of three years, Deborah DiSanzo,
left in 2018 to join a strategy team for IBM Cognitive Solutions, amid reports of growing unease about Watson Health’s performance clinically and as a business.
While IBM and BofA both declined Axios’ request for comment, IBM CEO Arvind Krishna admitted to Axios on HBO last year that the company had in the past overpromised on what it could deliver. “Healthcare is always going to turn out to be more subtle, as well as more regulated for the right reasons, than it is in other areas. And to me, that's natural. It is a decision that may impact somebody's life or death. You have to be more careful. So, in healthcare, it turns out maybe we were too optimistic.”
Ad Statistics
Times Displayed: 45539
Times Visited: 1299 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
In addition to a potential sale, IBM sold its i2 intelligence analysis product portfolio to Harris this week. This includes its i2 Analyst’s Notebook, i2 Enterprise Insight Analysis (EIA) and i2 iBase platforms. With these solutions, Harris will be able to offer “mission-critical” applications for national defense, law enforcement, maritime security and evidence management.
Back to HCB News
